Regadenoson 36000-0364
Product NDC
36000-0364- Manufacturer
- Baxter Healthcare Corporation
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- May 23, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA217455
Need to source Regadenoson? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Regadenoson | .08 mg/mL |
Drug Class
Adenosine Receptor Agonist [EPC]Adenosine Receptor Agonists [MoA]Pharmacologic Cardiac Stress Test Agent [EPC]
Packaging Options(1)
1 SYRINGE, PLASTIC in 1 CARTON (36000-364-01) / 5 mL in 1 SYRINGE, PLASTIC